ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.67
      0.00%
      US Tech 100
      17,585.60
      -0.15%
      Dow Jones
      39,056.39
      0.44%
      Brent Oil
      83.625
      0.08%
      Bitcoin
      61,367.23
      0.29%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG
      6. Biogen Inc (IDP)

      7. Biogen Inc (IDP) News

      IDP Biogen Inc

      204.50
      0.90 (0.44%)
      May 08 2024 - Closed
      Realtime Data
      Company Name Stock Ticker Symbol Market Type
      Biogen Inc IDP Tradegate Ordinary Share
        Price Change Change Percent Stock Price Last Traded
      0.90 0.44% 204.50 17:50:15
      Open Price Low Price High Price Close Price Prev Close
      204.60 201.70 205.00 204.50 203.60
      more quote information »

      Recent News

      Date Time Source Heading
      5/08/20249:05IHNWFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
      4/25/202416:05GLOBEBiogen Receives Positive CHMP Opinion for TOFIDENCE™..
      3/06/202407:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
      3/04/202416:15GLOBEBiogen Highlights New Data at the International Conference..
      2/23/202407:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
      2/12/202416:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
      1/31/202407:30GLOBEBiogen to Realign Resources for Alzheimer's Disease..
      12/19/202307:30GLOBECentralized Marketing Authorizations of Generic Versions of..
      12/15/202309:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
      12/14/202306:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
      11/06/202307:30GLOBEBiogen Appoints Monish Patolawala to its Board of Directors
      10/25/202317:26GLOBEEisai Presents New LEQEMBI® (lecanemab-irmb) Investigational..
      10/19/202307:30GLOBEBiogen to Present New Data at the Clinical Trials on..
      9/26/202308:59GLOBEBiogen Completes Acquisition of Reata Pharmaceuticals
      9/25/202301:02GLOBELEQEMBI® Intravenous Infusion (Lecanemab) Approved for the..
      9/06/202307:30GLOBEBiogen Appoints Jane Grogan as Head of Research
      8/04/202322:41GLOBEFDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral..
      7/28/202307:05GLOBEBiogen to Acquire Reata Pharmaceuticals
      7/19/202319:30GLOBEEisai Presents Latest Analysis of Lecanemab’s Effect on..
      7/06/202320:00GLOBEFDA Grants Traditional Approval for LEQEMBI®..
      6/12/202317:14GLOBEBiogen Announces Changes to Its Board of Directors
      6/09/202318:45GLOBEFDA Advisory Committee Votes Unanimously to Confirm the..
      5/15/202319:30GLOBEHealth Canada Accepts New Drug Submission for Lecanemab as..

      Your Recent History

      TG
      IDP
      Biogen
      Delayed Upgrade Clock